Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis

Toshiko Ito-Ihara,Takahiko Ono,Fumiaki Nogaki,Katsuo Suyama,Mari Tanaka,Satomi Yonemoto,Atsushi Fukatsu,Toru Kita,Kazuo Suzuki,Eri Muso

Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis

2005

Toshiko Ito-Ihara
Takahiko Ono
Fumiaki Nogaki
Katsuo Suyama
Mari Tanaka
Satomi Yonemoto
Atsushi Fukatsu
Toru Kita
Kazuo Suzuki
Eri Muso

Background: To determinewhether intravenous immunoglobulin (IVIg) cancontrol disease activity in patients with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associa

Keywords:

Medicine
Antibody
Rapidly progressive glomerulonephritis
Anti-neutrophil cytoplasmic antibody
Myeloperoxidase
Immunoglobulin E
Kidney disease
Immunology
Nephrology
Glomerulonephritis
Internal medicine
Prednisolone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations